Fulgent Genetics, Inc.
FLGT
$18.59
$0.693.86%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 6.23% | 1.01% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.23% | 1.01% | |||
| Cost of Revenue | -1.35% | 0.98% | |||
| Gross Profit | 18.97% | 1.06% | |||
| SG&A Expenses | 12.65% | 0.51% | |||
| Depreciation & Amortization | -0.05% | 0.15% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.97% | -1.24% | |||
| Operating Income | 5.53% | 9.66% | |||
| Income Before Tax | 56.59% | -65.26% | |||
| Income Tax Expenses | 51.67% | -80.70% | |||
| Earnings from Continuing Operations | 57.87% | -61.65% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 556.52% | -87.89% | |||
| Net Income | 59.80% | -68.17% | |||
| EBIT | 5.53% | 9.66% | |||
| EBITDA | 10.90% | 12.50% | |||
| EPS Basic | 60.11% | -66.41% | |||
| Normalized Basic EPS | 10.50% | 21.75% | |||
| EPS Diluted | 59.93% | -66.07% | |||
| Normalized Diluted EPS | 10.50% | 21.75% | |||
| Average Basic Shares Outstanding | 0.78% | 1.06% | |||
| Average Diluted Shares Outstanding | 0.78% | 1.06% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
